Cargando…
An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs
The epidermal growth factor receptor (EGFR) is a well-established target for cancer treatment. EGFR tyrosine kinase (TK) inhibitors, such as gefinitib and erlotinib, have been developed as anti-cancer drugs. Although non-small cell lung carcinoma with an activating EGFR mutation, L858R, responds wel...
Autores principales: | Bae, Young-Ki, Sung, Jee Young, Kim, Yong-Nyun, Kim, Sunshin, Hong, Kyeong Man, Kim, Heung Tae, Choi, Min Sung, Kwon, Jae Young, Shim, Jaegal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434183/ https://www.ncbi.nlm.nih.gov/pubmed/22957020 http://dx.doi.org/10.1371/journal.pone.0042441 |
Ejemplares similares
-
Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathway
por: Yun, Un-Jung, et al.
Publicado: (2017) -
FAM188B Downregulation Sensitizes Lung Cancer Cells to Anoikis via EGFR Downregulation and Inhibits Tumor Metastasis In Vivo
por: Jang, Eun-Ju, et al.
Publicado: (2021) -
Rab8 and Rabin8-Mediated Tumor Formation by Hyperactivated EGFR Signaling via FGFR Signaling
por: Choi, Junghwa, et al.
Publicado: (2020) -
Pygenic Acid A (PA) Sensitizes Metastatic Breast Cancer Cells to Anoikis and Inhibits Metastasis In Vivo
por: Lim, Ga-Eun, et al.
Publicado: (2020) -
Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities
por: Lee, Eun Jeong, et al.
Publicado: (2020)